The Effect of Oculo-Motor Exercises in Intermittent Exotropia
Launched by MEDIPOL UNIVERSITY · Sep 5, 2018
Trial Information
Current as of May 20, 2025
Completed
Keywords
ClinConnect Summary
50 volunteer school-aged children between 2-17 years of age) were included in our study. Oculo-motor home exercise protocols were given to all participants for 2 sessions per day for 6 weeks, and regular phone calls were made once a week. Participants were assessed cycloplegic refraction by autorefractometry, corrected and uncorrected visual acuity by snellen chart, ocular motility test, near and distant alternating prism cover test, streopsis test and patient satisfaction levels by intermittent exotropia survery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Be between 2 and 17 years of age
- • Intermittent exotropia diagnosis
- • To have mental capacity in the level to understand and do exercises
- Exclusion Criteria:
- • Not complying with age criteria
- • Constant exotropia
- • Having undergone eye surgery
- • Those with systemic disease that prevent exercise
About Medipol University
Medipol University is a leading academic institution dedicated to advancing medical research and clinical innovation. With a strong emphasis on interdisciplinary collaboration, the university conducts rigorous clinical trials aimed at improving patient outcomes and enhancing healthcare practices. Leveraging state-of-the-art facilities and a team of experienced researchers and healthcare professionals, Medipol University is committed to contributing to the global medical community through ethical research and the development of novel therapeutic strategies. The institution fosters an environment of academic excellence and integrity, ensuring that all trials adhere to the highest standards of safety and efficacy.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, Beykoz, Turkey
Patients applied
Trial Officials
Candan Algun
Study Director
Faculty of Health Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials